CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 401 filers reported holding CRISPR THERAPEUTICS AG in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $402,591 | -20.8% | 7,454 | 0.0% | 0.01% | -18.8% |
| Q1 2024 | $508,065 | +8.9% | 7,454 | 0.0% | 0.02% | -15.8% |
| Q4 2023 | $466,620 | +37.9% | 7,454 | 0.0% | 0.02% | +18.8% |
| Q3 2023 | $338,337 | -19.1% | 7,454 | 0.0% | 0.02% | -23.8% |
| Q2 2023 | $418,468 | +24.1% | 7,454 | 0.0% | 0.02% | +31.2% |
| Q1 2023 | $337,144 | +11.3% | 7,454 | 0.0% | 0.02% | -11.1% |
| Q4 2022 | $303,005 | -37.8% | 7,454 | 0.0% | 0.02% | -45.5% |
| Q3 2022 | $487,000 | +7.5% | 7,454 | 0.0% | 0.03% | +22.2% |
| Q2 2022 | $453,000 | -3.2% | 7,454 | 0.0% | 0.03% | +17.4% |
| Q1 2022 | $468,000 | -17.2% | 7,454 | 0.0% | 0.02% | +9.5% |
| Q4 2021 | $565,000 | -32.3% | 7,454 | 0.0% | 0.02% | -43.2% |
| Q3 2021 | $834,000 | -30.9% | 7,454 | 0.0% | 0.04% | -38.3% |
| Q2 2021 | $1,207,000 | +32.9% | 7,454 | 0.0% | 0.06% | +42.9% |
| Q1 2021 | $908,000 | -20.4% | 7,454 | 0.0% | 0.04% | -16.0% |
| Q4 2020 | $1,141,000 | +83.1% | 7,454 | 0.0% | 0.05% | +38.9% |
| Q3 2020 | $623,000 | +54.6% | 7,454 | +35.9% | 0.04% | +28.6% |
| Q2 2020 | $403,000 | +73.0% | 5,484 | 0.0% | 0.03% | +55.6% |
| Q1 2020 | $233,000 | -30.2% | 5,484 | 0.0% | 0.02% | -18.2% |
| Q4 2019 | $334,000 | +48.4% | 5,484 | 0.0% | 0.02% | +83.3% |
| Q3 2019 | $225,000 | -12.8% | 5,484 | 0.0% | 0.01% | +9.1% |
| Q2 2019 | $258,000 | +6.2% | 5,484 | 0.0% | 0.01% | -15.4% |
| Q3 2018 | $243,000 | -24.5% | 5,484 | 0.0% | 0.01% | -50.0% |
| Q2 2018 | $322,000 | – | 5,484 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
| Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
| EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
| NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
| ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
| NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
| Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
| Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |